Product Code: VMR11218694
The global demand for Stem Cell Assays Market is presumed to reach the market size of nearly USD 23.72 BN by 2030 from USD 4.66 BN in 2022 with a CAGR of 19.82% under the study period 2023 - 2030.
Stem cell assays are majorly adopted for measuring cellular and biochemical functions by using functional cells as diagnostic tools in researching new drugs. Stem cell assays involve the technique for analyzing living cells based on different parameters such as shape, size, and others. Stem cell assays measure cell growth, motility, and toxicity.
MARKET DYNAMICS:
The increase in approvals of clinical trials for stem cell-based therapy, high prevalence of chronic diseases, and increase in research-related activities in stem cells supplement the growth of the stem cell assay market. Moreover, the development of advanced medical infrastructures and the invention of emerging new technology has always aided in expanding the stem cell assay market. In line with this, an increase in the evolution of new technologies and a rise in the patient pool provide lucrative market opportunities for growth during the forecast period. Furthermore, the market is expected to grow due to increased funding for stem cell research and the rising cancer incidence worldwide. However, the shortage of skilled professionals for analyzing stem cells and the high cost of stem cell analysis instruments may impede the market's growth.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of stem cell assays. The growth and trends of stem cell assays industry provide a holistic approach to this study.
MARKET SEGMENTATION:
This section of the stem cell assays market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
By Cell Type
- Adult Stem Cells
- Mesenchymal Stem Cells
- Induced Pluripotent Stem Cells
- Hematopoietic Stem Cells
- Umbilical Cord Stem Cells
- Neural Stem Cells
- Human Embryonic Stems Cells
By Product & Service
- Instruments
- Flow Cytometers
- Microelectrode Arrays
- Cell Imaging & Analysis Systems
- Automated Cell Counters
- Kits
- Services
By Application
- Regenerative Medicine & Therapy Development
- Orthopedic, Musculoskeletal, And Spine Applications
- Dermatology Applications
- Cardiovascular Applications
- CNS Applications
- Oncology Applications
- Diabetes Applications
- Other Regenerative Medicine & Therapy Development Applications
- Drug Discovery & Development
- Clinical Research
By End User
- Biopharmaceutical & Biotechnology Companies
- Academic & Research Institutes
REGIONAL ANALYSIS:
This section covers the regional outlook, which accentuates current and future demand for the Stem Cell Assays market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Stem Cell Assays market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Danaher (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Promega Corporation (US), Bio-Techne Corporation (US),. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Market
- 2.2. Global Market Snapshot
3 . STEM CELL ASSAYS - INDUSTRY ANALYSIS
- 3.1. Introduction - Market Dynamics
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Opportunities
- 3.5. Industry Trends
- 3.6. Porter's Five Force Analysis
- 3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Cell Type
- 3.7.2 Market Attractiveness Analysis By Product & Service
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By End User
- 3.7.5 Market Attractiveness Analysis By Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Value Chain Analysis
- 4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
6 . GLOBAL STEM CELL ASSAYS MARKET ANALYSIS BY CELL TYPE
- 6.1 Overview by Cell Type
- 6.2 Historical and Forecast Data
- 6.3 Analysis by Cell Type
- 6.4 Adult Stem Cells Historic and Forecast Sales by Regions
- 6.5 Mesenchymal Stem Cells Historic and Forecast Sales by Regions
- 6.6 Induced Pluripotent Stem Cells Historic and Forecast Sales by Regions
- 6.7 Hematopoietic Stem Cells Historic and Forecast Sales by Regions
- 6.8 Umbilical Cord Stem Cells Historic and Forecast Sales by Regions
- 6.9 Neural Stem Cells Historic and Forecast Sales by Regions
- 6.10. Human Embryonic Stems Cells Historic and Forecast Sales by Regions
7 . GLOBAL STEM CELL ASSAYS MARKET ANALYSIS BY PRODUCT & SERVICE
- 7.1 Overview by Product & Service
- 7.2 Historical and Forecast Data
- 7.3 Analysis by Product & Service
- 7.4 Instruments Historic and Forecast Sales by Regions
- 7.5 Flow Cytometers Historic and Forecast Sales by Regions
- 7.6 Microelectrode Arrays Historic and Forecast Sales by Regions
- 7.7 Cell Imaging & Analysis Systems Historic and Forecast Sales by Regions
- 7.8 Automated Cell Counters Historic and Forecast Sales by Regions
- 7.9 Kits Historic and Forecast Sales by Regions
- 7.10. Services Historic and Forecast Sales by Regions
8 . GLOBAL STEM CELL ASSAYS MARKET ANALYSIS BY APPLICATION
- 8.1 Overview by Application
- 8.2 Historical and Forecast Data
- 8.3 Analysis by Application
- 8.4 Regenerative Medicine & Therapy Development Historic and Forecast Sales by Regions
- 8.5 Orthopedic, Musculoskeletal, And Spine Applications Historic and Forecast Sales by Regions
- 8.6 Dermatology Applications Historic and Forecast Sales by Regions
- 8.7 Cardiovascular Applications Historic and Forecast Sales by Regions
- 8.8 CNS Applications Historic and Forecast Sales by Regions
- 8.9 Oncology Applications Historic and Forecast Sales by Regions
- 8.10. Diabetes Applications Historic and Forecast Sales by Regions
- 8.11 Other Regenerative Medicine & Therapy Development Applications Historic and Forecast Sales by Regions
- 8.12 Drug Discovery & Development Historic and Forecast Sales by Regions
- 8.13 Clinical Research Historic and Forecast Sales by Regions
9 . GLOBAL STEM CELL ASSAYS MARKET ANALYSIS BY END USER
- 9.1 Overview by End User
- 9.2 Historical and Forecast Data
- 9.3 Analysis by End User
- 9.4 Biopharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
- 9.5 Academic & Research Institutes Historic and Forecast Sales by Regions
10 . GLOBAL STEM CELL ASSAYS MARKET ANALYSIS BY GEOGRAPHY
- 10.1. Regional Outlook
- 10.2. Introduction
- 10.3. North America Sales Analysis
- 10.3.1. Overview, Historic and Forecast Sales Analysis
- 10.3.2. North America By Segment Sales Analysis
- 10.3.3. North America By Country Sales Analysis
- 10.3.4. United State Sales Analysis
- 10.3.5. Canada Sales Analysis
- 10.3.6. Mexico Sales Analysis
- 10.4. Europe Sales Analysis
- 10.4.1. Overview, Historic and Forecast Sales Analysis
- 10.4.2. Europe by Segment Sales Analysis
- 10.4.3. Europe by Country Sales Analysis
- 10.4.4. United Kingdom Sales Analysis
- 10.4.5. France Sales Analysis
- 10.4.6. Germany Sales Analysis
- 10.4.7. Italy Sales Analysis
- 10.4.8. Russia Sales Analysis
- 10.4.9. Rest Of Europe Sales Analysis
- 10.5. Asia Pacific Sales Analysis
- 10.5.1. Overview, Historic and Forecast Sales Analysis
- 10.5.2. Asia Pacific by Segment Sales Analysis
- 10.5.3. Asia Pacific by Country Sales Analysis
- 10.5.4. China Sales Analysis
- 10.5.5. India Sales Analysis
- 10.5.6. Japan Sales Analysis
- 10.5.7. South Korea Sales Analysis
- 10.5.8. Australia Sales Analysis
- 10.5.9. Rest Of Asia Pacific Sales Analysis
- 10.6. Latin America Sales Analysis
- 10.6.1. Overview, Historic and Forecast Sales Analysis
- 10.6.2. Latin America by Segment Sales Analysis
- 10.6.3. Latin America by Country Sales Analysis
- 10.6.4. Brazil Sales Analysis
- 10.6.5. Argentina Sales Analysis
- 10.6.6. Peru Sales Analysis
- 10.6.7. Chile Sales Analysis
- 10.6.8. Rest of Latin America Sales Analysis
- 10.7. Middle East & Africa Sales Analysis
- 10.7.1. Overview, Historic and Forecast Sales Analysis
- 10.7.2. Middle East & Africa by Segment Sales Analysis
- 10.7.3. Middle East & Africa by Country Sales Analysis
- 10.7.4. Saudi Arabia Sales Analysis
- 10.7.5. UAE Sales Analysis
- 10.7.6. Israel Sales Analysis
- 10.7.7. South Africa Sales Analysis
- 10.7.8. Rest Of Middle East And Africa Sales Analysis
11 . COMPETITIVE LANDSCAPE OF THE STEM CELL ASSAYS COMPANIES
- 11.1. Stem Cell Assays Market Competition
- 11.2. Partnership/Collaboration/Agreement
- 11.3. Merger And Acquisitions
- 11.4. New Product Launch
- 11.5. Other Developments
12 . COMPANY PROFILES OF STEM CELL ASSAYS INDUSTRY
- 12.1. Top Company Share Analysis
- 12.2. Market Concentration Rate
- 12.3. Thermo Fisher Scientific Inc. (US)
- 12.3.1. Company Overview
- 12.3.2. Company Revenue
- 12.3.3. Products
- 12.3.4. Recent Developments
- 12.4. Merck KGaA (Germany)
- 12.4.1. Company Overview
- 12.4.2. Company Revenue
- 12.4.3. Products
- 12.4.4. Recent Developments
- 12.5. Danaher (US)
- 12.5.1. Company Overview
- 12.5.2. Company Revenue
- 12.5.3. Products
- 12.5.4. Recent Developments
- 12.6. Becton
- 12.6.1. Company Overview
- 12.6.2. Company Revenue
- 12.6.3. Products
- 12.6.4. Recent Developments
- 12.7. Dickinson and Company (US)
- 12.7.1. Company Overview
- 12.7.2. Company Revenue
- 12.7.3. Products
- 12.7.4. Recent Developments
- 12.8. Bio-Rad Laboratories (US)
- 12.8.1. Company Overview
- 12.8.2. Company Revenue
- 12.8.3. Products
- 12.8.4. Recent Developments
- 12.9. Promega Corporation (US)
- 12.9.1. Company Overview
- 12.9.2. Company Revenue
- 12.9.3. Products
- 12.9.4. Recent Developments
- 12.10. Bio-Techne Corporation (US)
- 12.10.1. Company Overview
- 12.10.2. Company Revenue
- 12.10.3. Products
- 12.10.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies